Singapore

Singapore

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.69 (2.51 - 2.86) 2019 Modelled IHME
2.67 (2.49 - 2.85) 2018 Modelled IHME
2.66 (2.47 - 2.87) 2017 Modelled IHME
2.65 (2.47 - 2.82) 2016 Modelled IHME
2.65 (2.47 - 2.83) 2015 Modelled IHME
2.66 (2.48 - 2.83) 2014 Modelled IHME
2.69 (2.51 - 2.85) 2013 Modelled IHME
2.73 (2.55 - 2.90) 2012 Modelled IHME
2.77 (2.59 - 2.96) 2011 Modelled IHME
2.81 (2.63 - 3.03) 2010 Modelled IHME
2.85 (2.67 - 3.04) 2009 Modelled IHME
2.9 (2.71 - 3.09) 2008 Modelled IHME
2.95 (2.75 - 3.14) 2007 Modelled IHME
3 (2.79 - 3.20) 2006 Modelled IHME
3.05 (2.82 - 3.27) 2005 Modelled IHME
3.11 (2.87 - 3.32) 2004 Modelled IHME
3.17 (2.93 - 3.38) 2003 Modelled IHME
3.23 (2.99 - 3.45) 2002 Modelled IHME
3.29 (3.02 - 3.54) 2001 Modelled IHME
3.34 (3.05 - 3.61) 2000 Modelled IHME
3.39 (3.12 - 3.66) 1999 Modelled IHME
3.44 (3.18 - 3.70) 1998 Modelled IHME
3.49 (3.23 - 3.75) 1997 Modelled IHME
3.54 (3.28 - 3.81) 1996 Modelled IHME
3.59 (3.31 - 3.87) 1995 Modelled IHME
3.65 (3.39 - 3.93) 1994 Modelled IHME
3.71 (3.44 - 4.01) 1993 Modelled IHME
3.78 (3.50 - 4.09) 1992 Modelled IHME
3.84 (3.55 - 4.19) 1991 Modelled IHME
3.91 (3.60 - 4.32) 1990 Modelled IHME
2.61 (2.08 - 3.19) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.1 (0.08 - 0.14) 2019 Modelled IHME
0.1 (0.08 - 0.13) 2018 Modelled IHME
0.1 (0.08 - 0.14) 2017 Modelled IHME
0.11 (0.08 - 0.14) 2016 Modelled IHME
0.11 (0.08 - 0.15) 2015 Modelled IHME
0.11 (0.08 - 0.15) 2014 Modelled IHME
0.11 (0.09 - 0.14) 2013 Modelled IHME
0.11 (0.09 - 0.14) 2012 Modelled IHME
0.11 (0.09 - 0.14) 2011 Modelled IHME
0.11 (0.08 - 0.14) 2010 Modelled IHME
0.11 (0.09 - 0.15) 2009 Modelled IHME
0.12 (0.09 - 0.15) 2008 Modelled IHME
0.13 (0.10 - 0.17) 2007 Modelled IHME
0.13 (0.10 - 0.17) 2006 Modelled IHME
0.14 (0.11 - 0.18) 2005 Modelled IHME
0.14 (0.11 - 0.18) 2004 Modelled IHME
0.14 (0.11 - 0.18) 2003 Modelled IHME
0.14 (0.11 - 0.18) 2002 Modelled IHME
0.14 (0.11 - 0.18) 2001 Modelled IHME
0.14 (0.11 - 0.19) 2000 Modelled IHME
0.15 (0.11 - 0.19) 1999 Modelled IHME
0.15 (0.12 - 0.20) 1998 Modelled IHME
0.16 (0.13 - 0.21) 1997 Modelled IHME
0.18 (0.14 - 0.23) 1996 Modelled IHME
0.19 (0.15 - 0.25) 1995 Modelled IHME
0.22 (0.17 - 0.28) 1994 Modelled IHME
0.26 (0.20 - 0.33) 1993 Modelled IHME
0.31 (0.24 - 0.40) 1992 Modelled IHME
0.37 (0.28 - 0.48) 1991 Modelled IHME
0.43 (0.33 - 0.57) 1990 Modelled IHME
0.47 (0.32 - 0.66) 2015 Modelled WHO
0.3 2010 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.87 (7.41 - 10.40) 2019 Modelled IHME
8.64 (7.25 - 10) 2018 Modelled IHME
8.32 (6.98 - 9.56) 2017 Modelled IHME
8.2 (6.96 - 9.38) 2016 Modelled IHME
8.02 (6.83 - 9.17) 2015 Modelled IHME
7.93 (6.78 - 9.01) 2014 Modelled IHME
7.8 (6.73 - 8.81) 2013 Modelled IHME
7.71 (6.65 - 8.71) 2012 Modelled IHME
7.64 (6.60 - 8.61) 2011 Modelled IHME
7.55 (6.56 - 8.48) 2010 Modelled IHME
7.43 (6.46 - 8.32) 2009 Modelled IHME
7.52 (6.54 - 8.40) 2008 Modelled IHME
7.51 (6.53 - 8.43) 2007 Modelled IHME
7.38 (6.42 - 8.30) 2006 Modelled IHME
7.45 (6.49 - 8.37) 2005 Modelled IHME
7.63 (6.69 - 8.54) 2004 Modelled IHME
7.58 (6.65 - 8.47) 2003 Modelled IHME
7.47 (6.60 - 8.34) 2002 Modelled IHME
7.34 (6.53 - 8.14) 2001 Modelled IHME
7.49 (6.66 - 8.31) 2000 Modelled IHME
7.4 (6.59 - 8.18) 1999 Modelled IHME
7.34 (6.51 - 8.11) 1998 Modelled IHME
7.34 (6.57 - 8.08) 1997 Modelled IHME
7.47 (6.71 - 8.21) 1996 Modelled IHME
7.61 (6.84 - 8.38) 1995 Modelled IHME
7.46 (6.70 - 8.22) 1994 Modelled IHME
7.33 (6.58 - 8.07) 1993 Modelled IHME
7.42 (6.69 - 8.14) 1992 Modelled IHME
7.57 (6.83 - 8.30) 1991 Modelled IHME
7.87 (7.13 - 8.60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
502 (420 - 588) 2019 Modelled IHME
487 (409 - 565) 2018 Modelled IHME
467 (392 - 537) 2017 Modelled IHME
460 (390 - 526) 2016 Modelled IHME
444 (378 - 508) 2015 Modelled IHME
434 (371 - 493) 2014 Modelled IHME
421 (363 - 476) 2013 Modelled IHME
409 (353 - 463) 2012 Modelled IHME
396 (342 - 446) 2011 Modelled IHME
383 (333 - 431) 2010 Modelled IHME
371 (322 - 415) 2009 Modelled IHME
364 (317 - 407) 2008 Modelled IHME
345 (299 - 387) 2007 Modelled IHME
325 (283 - 365) 2006 Modelled IHME
318 (277 - 357) 2005 Modelled IHME
318 (279 - 356) 2004 Modelled IHME
312 (274 - 349) 2003 Modelled IHME
312 (276 - 348) 2002 Modelled IHME
304 (270 - 337) 2001 Modelled IHME
302 (268 - 335) 2000 Modelled IHME
293 (261 - 324) 1999 Modelled IHME
288 (255 - 319) 1998 Modelled IHME
279 (249 - 307) 1997 Modelled IHME
274 (246 - 301) 1996 Modelled IHME
268 (241 - 296) 1995 Modelled IHME
255 (229 - 281) 1994 Modelled IHME
243 (218 - 267) 1993 Modelled IHME
240 (216 - 263) 1992 Modelled IHME
237 (214 - 260) 1991 Modelled IHME
240 (217 - 262) 1990 Modelled IHME
727 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
55 (45 - 66) 2019 Modelled IHME
56 (45 - 66) 2018 Modelled IHME
56 (45 - 66) 2017 Modelled IHME
56 (46 - 66) 2016 Modelled IHME
56 (46 - 66) 2015 Modelled IHME
56 (46 - 66) 2014 Modelled IHME
57 (47 - 66) 2013 Modelled IHME
57 (47 - 67) 2012 Modelled IHME
57 (48 - 67) 2011 Modelled IHME
58 (48 - 67) 2010 Modelled IHME
58 (48 - 68) 2009 Modelled IHME
59 (49 - 68) 2008 Modelled IHME
59 (49 - 68) 2007 Modelled IHME
59 (49 - 69) 2006 Modelled IHME
59 (49 - 69) 2005 Modelled IHME
59 (49 - 69) 2004 Modelled IHME
60 (50 - 69) 2003 Modelled IHME
61 (51 - 70) 2002 Modelled IHME
61 (52 - 70) 2001 Modelled IHME
62 (53 - 71) 2000 Modelled IHME
62 (53 - 71) 1999 Modelled IHME
62 (53 - 71) 1998 Modelled IHME
62 (53 - 71) 1997 Modelled IHME
62 (53 - 71) 1996 Modelled IHME
62 (53 - 71) 1995 Modelled IHME
62 (53 - 71) 1994 Modelled IHME
62 (53 - 71) 1993 Modelled IHME
63 (54 - 72) 1992 Modelled IHME
63 (54 - 72) 1991 Modelled IHME
64 (55 - 72) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
91 2017 Survey/reported WHO/UNICEF
91 2016 Survey/reported WHO/UNICEF
71 2015 Survey/reported WHO/UNICEF
68 2014 Survey/reported WHO/UNICEF
68 2013 Survey/reported WHO/UNICEF
67 2012 Survey/reported WHO/UNICEF
69 2011 Survey/reported WHO/UNICEF
69 2010 Survey/reported WHO/UNICEF
69 2009 Survey/reported WHO/UNICEF
71 2008 Survey/reported WHO/UNICEF
72 2007 Survey/reported WHO/UNICEF
74 2006 Survey/reported WHO/UNICEF
74 2005 Survey/reported WHO/UNICEF
72 2004 Survey/reported WHO/UNICEF
77 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2018 Survey/reported WHO/UNICEF
96 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
96 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
97 2000 Survey/reported WHO/UNICEF
96 1999 Survey/reported WHO/UNICEF
96 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
96 1996 Survey/reported WHO/UNICEF
96 1995 Survey/reported WHO/UNICEF
94 1994 Survey/reported WHO/UNICEF
90 1993 Survey/reported WHO/UNICEF
78 1992 Survey/reported WHO/UNICEF
76 1991 Survey/reported WHO/UNICEF
74 1990 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.58 (0.47 - 0.72) 2019 Modelled IHME
0.57 (0.46 - 0.70) 2018 Modelled IHME
0.55 (0.45 - 0.68) 2017 Modelled IHME
0.54 (0.44 - 0.66) 2016 Modelled IHME
0.53 (0.43 - 0.65) 2015 Modelled IHME
0.52 (0.42 - 0.64) 2014 Modelled IHME
0.51 (0.42 - 0.63) 2013 Modelled IHME
0.51 (0.41 - 0.62) 2012 Modelled IHME
0.5 (0.41 - 0.62) 2011 Modelled IHME
0.5 (0.40 - 0.61) 2010 Modelled IHME
0.49 (0.40 - 0.61) 2009 Modelled IHME
0.49 (0.40 - 0.60) 2008 Modelled IHME
0.49 (0.39 - 0.60) 2007 Modelled IHME
0.49 (0.39 - 0.60) 2006 Modelled IHME
0.48 (0.39 - 0.60) 2005 Modelled IHME
0.48 (0.39 - 0.59) 2004 Modelled IHME
0.48 (0.39 - 0.59) 2003 Modelled IHME
0.47 (0.38 - 0.59) 2002 Modelled IHME
0.47 (0.38 - 0.59) 2001 Modelled IHME
0.47 (0.38 - 0.59) 2000 Modelled IHME
0.47 (0.38 - 0.58) 1999 Modelled IHME
0.47 (0.37 - 0.58) 1998 Modelled IHME
0.47 (0.37 - 0.58) 1997 Modelled IHME
0.46 (0.37 - 0.58) 1996 Modelled IHME
0.46 (0.37 - 0.57) 1995 Modelled IHME
0.46 (0.37 - 0.57) 1994 Modelled IHME
0.47 (0.37 - 0.57) 1993 Modelled IHME
0.47 (0.37 - 0.58) 1992 Modelled IHME
0.47 (0.37 - 0.58) 1991 Modelled IHME
0.47 (0.38 - 0.59) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
42.5 (39.10 - 45.90) 2006 Survey/reported Winslow M et al, 2007

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.88 (2.75 - 5.07) 2019 Modelled IHME
3.67 (2.63 - 4.78) 2018 Modelled IHME
3.5 (2.53 - 4.58) 2017 Modelled IHME
3.42 (2.48 - 4.47) 2016 Modelled IHME
3.34 (2.41 - 4.36) 2015 Modelled IHME
3.27 (2.37 - 4.28) 2014 Modelled IHME
3.17 (2.30 - 4.13) 2013 Modelled IHME
3.08 (2.25 - 4.03) 2012 Modelled IHME
3 (2.18 - 3.91) 2011 Modelled IHME
2.91 (2.11 - 3.79) 2010 Modelled IHME
2.82 (2.05 - 3.68) 2009 Modelled IHME
2.81 (2.05 - 3.65) 2008 Modelled IHME
2.8 (2.04 - 3.64) 2007 Modelled IHME
2.74 (1.99 - 3.56) 2006 Modelled IHME
2.73 (1.98 - 3.55) 2005 Modelled IHME
2.78 (2.03 - 3.61) 2004 Modelled IHME
2.66 (1.95 - 3.43) 2003 Modelled IHME
2.51 (1.85 - 3.22) 2002 Modelled IHME
2.39 (1.76 - 3.05) 2001 Modelled IHME
2.36 (1.73 - 3.02) 2000 Modelled IHME
2.27 (1.68 - 2.91) 1999 Modelled IHME
2.23 (1.65 - 2.84) 1998 Modelled IHME
2.22 (1.66 - 2.81) 1997 Modelled IHME
2.23 (1.68 - 2.82) 1996 Modelled IHME
2.25 (1.70 - 2.85) 1995 Modelled IHME
2.15 (1.63 - 2.70) 1994 Modelled IHME
2.08 (1.56 - 2.61) 1993 Modelled IHME
2.02 (1.53 - 2.55) 1992 Modelled IHME
1.98 (1.50 - 2.50) 1991 Modelled IHME
1.99 (1.50 - 2.51) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
220 (156 - 287) 2019 Modelled IHME
207 (148 - 270) 2018 Modelled IHME
196 (142 - 257) 2017 Modelled IHME
192 (139 - 250) 2016 Modelled IHME
185 (134 - 241) 2015 Modelled IHME
179 (130 - 234) 2014 Modelled IHME
171 (124 - 223) 2013 Modelled IHME
164 (120 - 214) 2012 Modelled IHME
155 (113 - 203) 2011 Modelled IHME
148 (107 - 193) 2010 Modelled IHME
141 (102 - 184) 2009 Modelled IHME
136 (99 - 177) 2008 Modelled IHME
128 (93 - 167) 2007 Modelled IHME
120 (88 - 157) 2006 Modelled IHME
117 (85 - 152) 2005 Modelled IHME
116 (84 - 151) 2004 Modelled IHME
109 (80 - 141) 2003 Modelled IHME
105 (77 - 134) 2002 Modelled IHME
99 (73 - 126) 2001 Modelled IHME
95 (70 - 122) 2000 Modelled IHME
90 (66 - 115) 1999 Modelled IHME
88 (65 - 111) 1998 Modelled IHME
84 (63 - 107) 1997 Modelled IHME
82 (62 - 103) 1996 Modelled IHME
79 (60 - 100) 1995 Modelled IHME
74 (56 - 92) 1994 Modelled IHME
69 (52 - 86) 1993 Modelled IHME
65 (49 - 82) 1992 Modelled IHME
62 (47 - 78) 1991 Modelled IHME
61 (46 - 77) 1990 Modelled IHME
134 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
29 (20 - 39) 2019 Modelled IHME
29 (20 - 38) 2018 Modelled IHME
29 (20 - 38) 2017 Modelled IHME
29 (20 - 38) 2016 Modelled IHME
29 (20 - 38) 2015 Modelled IHME
28 (20 - 38) 2014 Modelled IHME
28 (19 - 37) 2013 Modelled IHME
28 (19 - 37) 2012 Modelled IHME
27 (19 - 37) 2011 Modelled IHME
27 (18 - 36) 2010 Modelled IHME
27 (18 - 36) 2009 Modelled IHME
26 (18 - 35) 2008 Modelled IHME
26 (18 - 35) 2007 Modelled IHME
26 (18 - 35) 2006 Modelled IHME
26 (18 - 35) 2005 Modelled IHME
26 (18 - 35) 2004 Modelled IHME
25 (17 - 34) 2003 Modelled IHME
25 (17 - 33) 2002 Modelled IHME
24 (17 - 33) 2001 Modelled IHME
24 (16 - 32) 2000 Modelled IHME
24 (16 - 32) 1999 Modelled IHME
24 (16 - 31) 1998 Modelled IHME
24 (16 - 32) 1997 Modelled IHME
24 (16 - 32) 1996 Modelled IHME
24 (16 - 32) 1995 Modelled IHME
24 (16 - 32) 1994 Modelled IHME
24 (16 - 32) 1993 Modelled IHME
23 (16 - 31) 1992 Modelled IHME
23 (16 - 31) 1991 Modelled IHME
23 (15 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.69 (%)
2019
(2.51 - 2.86(%))
IHME
HCV (RNA/cAg+)
0.58 (%)
2019
(0.47 - 0.72(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
502
2019
(420 - 588)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
220
2019
(156 - 287)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.30 (%)
2010, survey/surveillance
WHO WPRO, Woodring J et al, 2017

Prevalence PWID

HCV
0
, latest modelled

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
91 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs